z-logo
open-access-imgOpen Access
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Author(s) -
John H. Stone,
Matthew J. Frigault,
Naomi SerlingBoyd,
Ana D. Fernandes,
Liam Harvey,
Andrea S. Foulkes,
Nora Horick,
Brian C. Healy,
Ruta Shah,
Ana Maria Bensaci,
Ann E. Woolley,
Sarah Nikiforow,
Nina Lin,
Manish Sagar,
Harry Schrager,
David S. Huckins,
Matthew Axelrod,
Michael Pincus,
Jorge Fleisher,
Chana A. Sacks,
Michael Dougan,
Crystal M. North,
Yuan-Di Halvorsen,
Tara Thurber,
Zeina Dagher,
Allison K. Scherer,
Rachel Wallwork,
Arthur Y. Kim,
Sara Schoenfeld,
Pritha Sen,
Tomas G. Neilan,
Cory A. Perugino,
Sebastian Unizony,
Deborah Collier,
Mark Matza,
Janeth M Yinh,
Kathryn Bowman,
Eric A. Meyerowitz,
Amna Zafar,
Zsófia D. Drobni,
Marcy B. Bolster,
Minna J. Kohler,
Kristin M. D’Silva,
Jonathan Dau,
Megan Lockwood,
Caroline Cubbison,
Brittany Weber,
Michael K. Mansour
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2028836
Subject(s) - tocilizumab , covid-19 , medicine , virology , infectious disease (medical specialty) , outbreak , disease
The efficacy of interleukin-6 receptor blockade in hospitalized patients with coronavirus disease 2019 (Covid-19) who are not receiving mechanical ventilation is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom